What is the purpose of this trial?
We hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. the Artemis system will be used to collect one extra research biopsy from each ROI. An average of 2 ROIs are identified for each case; therefore an average of 2 additional biopsies would be required for this research study. These research biopsies will not affect prostate biopsies collected as part of standard clinical care.
Ages: 18 - 80 years
Gender: Male only
Yale University School of Medicine
Start Date: 06/24/2013
End Date: 07/01/2017
Last Updated: 02/22/2018
Study HIC#: 1304011902